Pediatric-type Therapy With Pre-transplant Blinatumomab for HR Patients - Phase II Study
Conditions: Philadelphia-Negative ALL; High-Risk Cancer Intervention: Drug: Blinatumomab Sponsor: Israeli Medical Association Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials